SEER, INC. Operating Income
SEER, INC. (SEER) reported Operating Income of -$16.84 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-11
- SEER, INC. operating income (loss) for the quarter ending 2026-06-30 was -$16.84M.
- SEER, INC. operating income (loss) for the quarter ending 2026-03-31 was -$17.26M.
- SEER, INC. operating income (loss) for the quarter ending 2025-12-31 was -$17.39M.
- SEER, INC. operating income (loss) for the quarter ending 2025-09-30 was -$19.35M.
- SEER, INC. operating income (loss) for fiscal 2025 was -$77.99M.
- SEER, INC. operating income (loss) for fiscal 2024 was -$100.10M.
- SEER, INC. operating income (loss) for fiscal 2023 was -$103.46M.
- SEER, INC. operating income (loss) for fiscal 2022 was -$97.23M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$16.84M 10-Q · filed 2026-08-11 | -$34.10M 10-Q · filed 2026-08-11 | -$51.48M derived: sum of 3 quarters · filed 2026-08-11 | -$70.83M derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | -$17.26M 10-Q · filed 2026-05-13 | -$34.64M derived: sum of 2 quarters · filed 2026-05-13 | -$53.99M derived: sum of 3 quarters · filed 2026-05-13 | -$74.52M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | -$17.39M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | -$36.73M derived: sum of 2 quarters · filed 2026-03-02 | -$57.26M derived: sum of 3 quarters · filed 2026-08-11 | -$77.99M 10-K · filed 2026-03-02 |
| 2025-09-30 | -$19.35M 10-Q · filed 2025-11-06 | -$39.88M derived: sum of 2 quarters · filed 2026-08-11 | -$60.61M 10-Q · filed 2025-11-06 | -$84.09M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | -$20.53M 10-Q · filed 2026-08-11 | -$41.26M 10-Q · filed 2026-08-11 | -$64.75M derived: sum of 3 quarters · filed 2026-08-11 | -$89.07M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | -$20.73M 10-Q · filed 2026-05-13 | -$44.22M derived: sum of 2 quarters · filed 2026-05-13 | -$68.54M derived: sum of 3 quarters · filed 2026-05-13 | -$95.64M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | -$23.49M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | -$47.81M derived: sum of 2 quarters · filed 2026-03-02 | -$74.91M derived: sum of 3 quarters · filed 2026-03-02 | -$100.10M 10-K · filed 2026-03-02 |
| 2024-09-30 | -$24.32M 10-Q · filed 2025-11-06 | -$51.42M derived: sum of 2 quarters · filed 2025-11-06 | -$76.61M 10-Q · filed 2025-11-06 | -$98.84M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | -$27.10M 10-Q · filed 2025-08-06 | -$52.29M 10-Q · filed 2025-08-06 | -$74.52M derived: sum of 3 quarters · filed 2025-08-06 | -$100.36M derived: sum of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | -$25.19M 10-Q · filed 2025-05-13 | -$47.42M derived: sum of 2 quarters · filed 2025-05-13 | -$73.27M derived: sum of 3 quarters · filed 2025-05-13 | -$101.21M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | -$22.23M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | -$48.08M derived: sum of 2 quarters · filed 2025-03-03 | -$76.02M derived: sum of 3 quarters · filed 2025-03-03 | -$103.46M 10-K · filed 2025-03-03 |
| 2023-09-30 | -$25.84M 10-Q · filed 2024-11-06 | -$53.79M derived: sum of 2 quarters · filed 2024-11-06 | -$81.23M 10-Q · filed 2024-11-06 | -$106.18M derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | -$27.94M 10-Q · filed 2024-08-08 | -$55.39M 10-Q · filed 2024-08-08 | -$80.33M derived: sum of 3 quarters · filed 2024-08-08 | -$105.40M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | -$27.45M 10-Q · filed 2024-05-08 | -$52.39M derived: sum of 2 quarters · filed 2024-05-08 | -$77.46M derived: sum of 3 quarters · filed 2024-05-08 | -$100.89M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | -$24.95M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-04 | -$50.02M derived: sum of 2 quarters · filed 2024-03-04 | -$73.45M derived: sum of 3 quarters · filed 2024-03-04 | -$97.23M 10-K · filed 2024-03-04 |
| 2022-09-30 | -$25.07M 10-Q · filed 2023-11-07 | -$48.50M derived: sum of 2 quarters · filed 2023-11-07 | -$72.29M 10-Q · filed 2023-11-07 | -$92.16M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | -$23.43M 10-Q · filed 2023-08-08 | -$47.22M 10-Q · filed 2023-08-08 | -$67.09M derived: sum of 3 quarters · filed 2023-08-08 | -$85.53M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | -$23.79M 10-Q · filed 2023-05-09 | -$43.66M derived: sum of 2 quarters · filed 2023-05-09 | -$62.09M derived: sum of 3 quarters · filed 2023-05-09 | -$78.76M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | -$19.87M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | -$38.30M derived: sum of 2 quarters · filed 2023-03-06 | -$54.98M derived: sum of 3 quarters · filed 2023-03-06 | -$71.47M 10-K · filed 2023-03-06 |
| 2021-09-30 | -$18.43M 10-Q · filed 2022-11-08 | -$35.10M derived: sum of 2 quarters · filed 2022-11-08 | -$51.60M 10-Q · filed 2022-11-08 | -$64.64M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | -$16.67M 10-Q · filed 2022-08-09 | -$33.17M 10-Q · filed 2022-08-09 | -$46.21M derived: sum of 3 quarters · filed 2022-08-09 | -$54.63M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | -$16.50M 10-Q · filed 2022-05-06 | -$29.54M derived: sum of 2 quarters · filed 2022-05-06 | -$37.95M derived: sum of 3 quarters · filed 2022-05-06 | -$44.32M derived: sum of 4 quarters · filed 2022-05-06 |
| 2020-12-31 | -$13.04M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$21.46M derived: sum of 2 quarters · filed 2022-03-01 | -$27.82M derived: sum of 3 quarters · filed 2022-03-01 | -$33.65M 10-K · filed 2022-03-01 |
| 2020-09-30 | -$8.42M 10-Q · filed 2021-11-09 | -$14.78M derived: sum of 2 quarters · filed 2021-11-09 | -$20.61M 10-Q · filed 2021-11-09 | |
| 2020-06-30 | -$6.37M 10-Q · filed 2021-08-12 | -$12.19M 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | -$5.83M 10-Q · filed 2021-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |